Reply by Authors
J Urol
.
2022 Nov;208(5):1036.
doi: 10.1097/JU.0000000000002885.02.
Epub 2022 Sep 12.
Authors
Paul Doan
1
2
,
Matthijs J Scheltema
1
2
3
,
Amer Amin
1
2
,
Ron Shnier
4
,
Bart Geboers
1
2
5
,
William Gondoputro
1
2
,
Daniel Moses
6
,
Pim J van Leeuwen
3
,
Anne Maree Haynes
2
,
Jayne Matthews
2
,
Phillip Brenner
1
,
Gordon O'Neill
1
,
Carlo Yuen
1
,
Warick Delprado
7
,
Phillip Stricker
1
,
James Thompson
1
2
Affiliations
1
St. Vincent's Prostate Cancer Centre, Department of Urology, Darlinghurst, Sydney, New South Wales, Australia.
2
Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Darlinghurst, Sydney, New South Wales, Australia.
3
Department of Urology, Amsterdam University Medical Centers (VUmc), Amsterdam, The Netherlands.
4
I-MED Radiology, Sydney, New South Wales, Australia.
5
Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers (VUmc), Amsterdam, The Netherlands.
6
Spectrum Medical Imaging, Sydney, New South Wales, Australia.
7
Douglas Hanly Moir Pathology, Sydney, New South Wales, Australia.
PMID:
36094874
DOI:
10.1097/JU.0000000000002885.02
No abstract available
Publication types
Comment